JNCCN Study Highlights Gaps in Patient Supportive Services at U.S. Cancer Centers

New research in the July 2021 issue of JNCCN indicates a need to increase substance use and mental health support capabilities at cancer centers across the United States. Researchers found 85.4% of centers offered mental health services but only 45.5% had chemical dependency services.

Focusing on Solutions to the Opioid Crisis, Foundation for Opioid Response Efforts (FORE) Announces Family- and Community-Based Initiatives to Prevent Substance Use Disorder and Overdose

Recognizing the urgent need for comprehensive approaches to opioid use disorder that address the needs of the entire family, the Foundation for Opioid Response Efforts (FORE) is today issuing a new Request for Proposals for projects that will engage and empower vulnerable families and communities to prevent opioid use disorder and overdose.

Predicting who may do best with psychedelic-assisted therapy

A new research review identifies personality traits that have been associated with positive and negative experiences on psychedelics being tested for therapeutic purposes in previous studies, information that could help predict how future clinical trial participants will respond to the drugs.

Researchers launch confidential helpline, 833-EMS-INTX, for Texas first responders to find help for substance use disorder

First responders in Texas can now call a confidential helpline to seek treatment for substance use and mental health disorders through a new clinical research program at The University of Texas Health Science Center at Houston (UTHealth). The Heroes Helpline comes at a time when first responders are serving on the front lines of the COVID-19 pandemic.

Study Reveals Pharmacy-level Barriers to Treatment for Opioid Use Disorder in Appalachian Kentucky

A new study led by University of Kentucky researcher April Young and Emory University researcher Hannah Cooper shows that a number of pharmacies in the Appalachian region of Kentucky are limiting the dispensing of buprenorphine, a medication used to treat opioid use disorder (OUD).

Parkdale Center and AANA Launch Free Virtual Support for Healthcare Professionals During COVID-19 Pandemic

Committed to supporting healthcare professionals serving on the frontlines of the COVID-19 pandemic, the Parkdale Center and American Association of Nurse Anesthetists (AANA) have launched the free “Support The Front” program to service healthcare professionals dealing with grief, trauma, exhaustion, and fear.

Battling treatment resistant opioid use disorder

Similar to treatment resistant depression, there is a subpopulation of those addicted to opioids who do not respond to standard opioid use disorder (OUD) treatments. In a new paper, an addiction expert at the Brown School at Washington University in St. Louis suggests a new category for these types of patients: treatment resistant opioid use disorder (TROUD).

Low Rates of Tobacco Dependence Treatment in Patients Hospitalized with Substance Use Disorders

June 21, 2019 – Tobacco dependence is very common in patients hospitalized with substance use disorders (SUDs) – but most don’t receive recommended treatment for tobacco dependence while in the hospital, reports a study in the Journal of Addiction Medicine,…